• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内源性大麻素系统与免疫:从临床到基础研究的探索。

, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back.

机构信息

Laboratory of Immunotherapy and Bone Marrow Transplantation, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.

出版信息

Int J Mol Sci. 2020 Jun 23;21(12):4448. doi: 10.3390/ijms21124448.

DOI:10.3390/ijms21124448
PMID:32585801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7352399/
Abstract

The plant contains numerous components, including cannabinoids and other active molecules. The phyto-cannabinoid activity is mediated by the endocannabinoid system. Cannabinoids affect the nervous system and play significant roles in the regulation of the immune system. While is not yet registered as a drug, the potential of cannabinoid-based medicines for the treatment of various conditions has led many countries to authorize their clinical use. However, the data from basic and medical research dedicated to medical is currently limited. A variety of pathological conditions involve dysregulation of the immune system. For example, in cancer, immune surveillance and cancer immuno-editing result in immune tolerance. On the other hand, in autoimmune diseases increased immune activity causes tissue damage. Immuno-modulating therapies can regulate the immune system and therefore the immune-regulatory properties of cannabinoids, suggest their use in the therapy of immune related disorders. In this contemporary review, we discuss the roles of the endocannabinoid system in immunity and explore the emerging data about the effects of cannabinoids on the immune response in different pathologies. In addition, we discuss the complexities of using cannabinoid-based treatments in each of these conditions.

摘要

该植物含有多种成分,包括大麻素和其他活性分子。植物大麻素的活性由内源性大麻素系统介导。大麻素影响神经系统,并在免疫系统的调节中发挥重要作用。虽然大麻素尚未被注册为药物,但基于大麻素的药物治疗各种疾病的潜力已促使许多国家授权其临床使用。然而,目前专门用于医学大麻的基础和医学研究的数据有限。多种病理状况涉及免疫系统的失调。例如,在癌症中,免疫监视和癌症免疫编辑导致免疫耐受。另一方面,在自身免疫性疾病中,免疫活性增加导致组织损伤。免疫调节疗法可以调节免疫系统,因此大麻素的免疫调节特性表明它们可用于治疗与免疫相关的疾病。在这篇当代综述中,我们讨论了内源性大麻素系统在免疫中的作用,并探讨了关于大麻素对不同病理中免疫反应影响的新兴数据。此外,我们还讨论了在这些情况下使用基于大麻素的治疗方法的复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ab/7352399/3f61107ab1b5/ijms-21-04448-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ab/7352399/9bc47cdd13dd/ijms-21-04448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ab/7352399/3f61107ab1b5/ijms-21-04448-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ab/7352399/9bc47cdd13dd/ijms-21-04448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ab/7352399/3f61107ab1b5/ijms-21-04448-g002.jpg

相似文献

1
, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back.内源性大麻素系统与免疫:从临床到基础研究的探索。
Int J Mol Sci. 2020 Jun 23;21(12):4448. doi: 10.3390/ijms21124448.
2
Cannabinoids and the gut: new developments and emerging concepts.大麻素与肠道:新进展与新兴概念。
Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1.
3
Endocannabinoid System: A Multi-Facet Therapeutic Target.内源性大麻素系统:一个多方面的治疗靶点。
Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339.
4
Phytocannabinoids and endocannabinoids.植物大麻素和内源性大麻素。
Curr Drug Abuse Rev. 2009 Jan;2(1):51-75. doi: 10.2174/1874473710902010051.
5
Therapeutic potential of the endocannabinoid system in the brain.内源性大麻素系统在大脑中的治疗潜力。
Mini Rev Med Chem. 2005 Jul;5(7):609-17. doi: 10.2174/1389557054368817.
6
Cannabinoid receptors as therapeutic targets.大麻素受体作为治疗靶点。
Annu Rev Pharmacol Toxicol. 2006;46:101-22. doi: 10.1146/annurev.pharmtox.46.120604.141254.
7
[News about therapeutic use of Cannabis and endocannabinoid system].[关于大麻和内源性大麻素系统治疗用途的新闻]
Med Clin (Barc). 2004 Mar 20;122(10):390-8. doi: 10.1016/s0025-7753(04)74251-7.
8
Medical Use of Cannabinoids.医用大麻素
Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1.
9
The endocannabinoid system as a target for the treatment of neurodegenerative disease.内源性大麻素系统作为治疗神经退行性疾病的靶点。
Br J Pharmacol. 2010 Jun;160(3):480-98. doi: 10.1111/j.1476-5381.2010.00735.x.
10
The endocannabinoid system and cancer: therapeutic implication.内源性大麻素系统与癌症:治疗意义。
Br J Pharmacol. 2011 Aug;163(7):1447-63. doi: 10.1111/j.1476-5381.2011.01327.x.

引用本文的文献

1
Cannabis Derivatives as Ingredients of Functional Foods to Combat the COVID-19 Pandemic.大麻衍生物作为功能性食品成分以对抗新冠疫情。
Foods. 2025 Aug 15;14(16):2830. doi: 10.3390/foods14162830.
2
Medicinal Plants for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Antiemetic, Chemosensitizing, and Immunomodulatory Mechanisms.用于化疗引起的恶心和呕吐的药用植物:抗呕吐、化学增敏和免疫调节机制的系统评价
Ther Clin Risk Manag. 2025 Jul 31;21:1187-1218. doi: 10.2147/TCRM.S531645. eCollection 2025.
3
Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS.

本文引用的文献

1
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?大麻二酚及其他非精神活性大麻素用于预防和治疗胃肠道疾病:有益的营养保健品?
Int J Mol Sci. 2020 Apr 26;21(9):3067. doi: 10.3390/ijms21093067.
2
The Endocannabinoid System: A Target for Cancer Treatment.内源性大麻素系统:癌症治疗的靶点。
Int J Mol Sci. 2020 Jan 23;21(3):747. doi: 10.3390/ijms21030747.
3
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
大麻素在神经退行性疾病和中枢神经系统炎症性疾病治疗中的抗炎作用。
Int J Mol Sci. 2025 Jul 8;26(14):6570. doi: 10.3390/ijms26146570.
4
Differential metabolic pathways underlie THC- and CBD-mediated inhibition of B-cell activation in both young and aged mice.不同的代谢途径是四氢大麻酚(THC)和大麻二酚(CBD)在年轻和老年小鼠中介导抑制B细胞活化的基础。
Front Immunol. 2025 Jun 17;16:1605474. doi: 10.3389/fimmu.2025.1605474. eCollection 2025.
5
The influence of genetics on the endocannabinoid system gene expression and relevance for targeting reproductive conditions.遗传学对内源性大麻素系统基因表达的影响及其与生殖疾病靶向治疗的相关性。
J Cannabis Res. 2025 May 29;7(1):29. doi: 10.1186/s42238-025-00275-x.
6
Beyond Infections: Exploring Immune-Mediated Pathways Linking Cannabis and Emerging Environmental Contaminants to Neurodevelopmental Outcomes.超越感染:探索将大麻和新兴环境污染物与神经发育结局联系起来的免疫介导途径。
Adv Exp Med Biol. 2025;1477:281-309. doi: 10.1007/978-3-031-89525-8_11.
7
Cannabinoids and the endocannabinoid system in liver diseases.大麻素与内源性大麻素系统在肝脏疾病中的作用
Clin Exp Hepatol. 2024 Dec;10(4):211-217. doi: 10.5114/ceh.2024.145358. Epub 2024 Dec 12.
8
Discovery of MAGL Inhibition by Lophine Derivatives: An Unexpected Finding from Chemiluminescent Assay Development.洛粉碱衍生物对单酰甘油脂肪酶(MAGL)的抑制作用的发现:化学发光分析方法开发中的意外发现。
Molecules. 2025 Apr 3;30(7):1605. doi: 10.3390/molecules30071605.
9
The Presence of the Endocannabinoid System in an In Vitro Model of Gorham-Stout Disease and Its Possible Role in the Pathogenesis.内源性大麻素系统在戈勒姆-斯托特病体外模型中的存在及其在发病机制中的可能作用。
Int J Mol Sci. 2025 Jan 28;26(3):1143. doi: 10.3390/ijms26031143.
10
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery.大麻素受体药理学进展:从受体结构洞察到配体发现
Acta Pharmacol Sin. 2025 Feb 5. doi: 10.1038/s41401-024-01472-9.
脂肪酸酰胺水解酶(FAAH)抑制剂作为潜在治疗药物的视角综述。
Eur J Med Chem. 2020 Feb 15;188:111953. doi: 10.1016/j.ejmech.2019.111953. Epub 2019 Dec 30.
4
Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens.大麻素衍生大麻素触发 CB2/PI3K 轴抑制口腔病原体的先天反应。
Front Immunol. 2019 Oct 15;10:2288. doi: 10.3389/fimmu.2019.02288. eCollection 2019.
5
Association between cannabis use and complications related to ulcerative colitis in hospitalized patients: A propensity matched retrospective cohort study.住院患者中大麻使用与溃疡性结肠炎相关并发症之间的关联:一项倾向匹配的回顾性队列研究。
Medicine (Baltimore). 2019 Aug;98(32):e16551. doi: 10.1097/MD.0000000000016551.
6
The heterogeneity and complexity of extracts as antitumor agents.提取物作为抗肿瘤药物的异质性和复杂性。
Oncotarget. 2019 Jun 25;10(41):4091-4106. doi: 10.18632/oncotarget.26983.
7
Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells.大麻素受体 1 阻断通过巨噬细胞中 miR-30e-5p 对 Delta-Like-4 的调节,减轻肥胖和脂肪组织 1 型炎症,从而下调 Th1 细胞。
Front Immunol. 2019 May 10;10:1049. doi: 10.3389/fimmu.2019.01049. eCollection 2019.
8
The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.2-花生四烯酸甘油在调节胰腺癌小鼠模型中肿瘤免疫微环境中的作用。
Biomed Pharmacother. 2019 Jul;115:108952. doi: 10.1016/j.biopha.2019.108952. Epub 2019 May 9.
9
Pharmacological evidence of medicinal cannabis in oncology: a systematic review.药用大麻在肿瘤学中的药理学证据:系统评价。
Support Care Cancer. 2019 Sep;27(9):3195-3207. doi: 10.1007/s00520-019-04774-5. Epub 2019 May 6.
10
Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.棕榈酸乙醇酰胺和大麻二酚可预防人肠道炎症诱导的通透性增加:一项随机、安慰剂对照、双盲对照临床试验。
Inflamm Bowel Dis. 2019 May 4;25(6):1006-1018. doi: 10.1093/ibd/izz017.